-transparent.png){kind=logo}
We have explored the requirements for the induction of the N-formyl-methionyl-leucyl-phenylalanine (FMLP) response in Daudi cells after anti-immunoglobulin treatment. Our results indicate that (a) induction of responsiveness to FMLP was observed in Daudi only after crosslinking of surface immunoglobulin by anti-immunoglobulin; (b) this induced responsiveness was not observed in Ramos or Wil-2 cells; (c) the F(ab')2 fragment was sufficient for the induction of the FMLP response, but the Fab fragment and the Fc fragment were ineffective; (d) of the many agents active in B lymphocyte regulation which were tested, none were as effective as anti-immunoglobulin in the induction of the FMLP response; and (e) three inhibitors of calcium mobilization (W-7 (N-(6-aminohexyl)-5-chloro-1-naphthalene sulfonamide), PMA (phorbol 12-myristate 13-acetate), and colchicine), acting on distinct mechanisms, inhibited both the calcium mobilization due to anti-immunoglobulin and the induction of responsiveness to FMLP. Our results suggest important determinants in the induction of a calcium-mobilizing FMLP response in cells of B lymphocyte lineage include (a) the cell type, (b) a selective requirement for activation via surface immunoglobulin, and (c) crosslinking of the surface immunoglobulin.
C I Kalunta, and
J S Kaptein, and
S J Scott, and
C K Lin, and
D G Gu, and
P M Lad
September 1979,
The Journal of cell biology,
C I Kalunta, and
J S Kaptein, and
S J Scott, and
C K Lin, and
D G Gu, and
P M Lad
March 1987,
Proceedings of the National Academy of Sciences of the United States of America,
C I Kalunta, and
J S Kaptein, and
S J Scott, and
C K Lin, and
D G Gu, and
P M Lad
June 1993,
The Journal of experimental medicine,
C I Kalunta, and
J S Kaptein, and
S J Scott, and
C K Lin, and
D G Gu, and
P M Lad
December 1977,
Cancer research,
C I Kalunta, and
J S Kaptein, and
S J Scott, and
C K Lin, and
D G Gu, and
P M Lad
November 2004,
Journal of molecular and cellular cardiology,
C I Kalunta, and
J S Kaptein, and
S J Scott, and
C K Lin, and
D G Gu, and
P M Lad
November 1988,
The American journal of physiology,
C I Kalunta, and
J S Kaptein, and
S J Scott, and
C K Lin, and
D G Gu, and
P M Lad
February 2001,
Physiological genomics,
C I Kalunta, and
J S Kaptein, and
S J Scott, and
C K Lin, and
D G Gu, and
P M Lad
July 2023,
Molecular brain,
C I Kalunta, and
J S Kaptein, and
S J Scott, and
C K Lin, and
D G Gu, and
P M Lad
June 1994,
The Journal of clinical investigation,
C I Kalunta, and
J S Kaptein, and
S J Scott, and
C K Lin, and
D G Gu, and
P M Lad
October 2000,
Anti-cancer drugs,
